profit from every $100 of sales.
$0$100
Labcorp Holdings
$372.32+0.02% today
+40.0% in 1 year
1-year low $250.391-year high $372.32
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $34.49 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Labcorp Holdings sold, what it kept, and what it did with the cash.
Sales went from $11.9 billion in 2022 to $14.0 billion in 2025, with $877 million of profit last year.
SalesProfit
Labcorp Holdings handed back 57% of the cash it generated last year.
Buybacks $450M$241M
Free cash flow 2025$1.2B
Bought back its own shares$450M
Paid as dividends$241M
Cash vs. debt$532M vs. $6.5B
Labcorp Holdings vs. similar companies
Labcorp Holdings grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Labcorp Holdings | 34.5× · Expensive | ||
 Illumina | 37.3× · Expensive | ||
 Quest Diagnostics | 28.8× · Fair price | ||
 Guardant Health | No profit yet | ||
 Exact Sciences | No profit yet |
Compare Labcorp Holdings with Quest Diagnostics · Natera
AI analysis
An AI analyst reads Labcorp Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 13,979 | 13,136 | 11,864 | 12,162 | 13,009 | 13,952 | |
| 4,953 | 4,992 | 3,709 | 3,365 | 3,624 | 4,013 | |
| – | – | 1,752 | 1,124 | 1,138 | 1,516 | |
| 3,070 | 3,626 | 1,954 | 1,346 | 1,811 | 2,013 | |
| 1,556 | 2,377 | 1,279 | 418 | 746 | 877 | |
| 15.88 | 24.39 | 13.97 | 4.77 | 8.84 | 10.46 | |
| 35.4% | 38.0% | 31.3% | 27.7% | 27.9% | 28.8% | |
| – | – | 14.8% | 9.2% | 8.7% | 10.9% | |
| 11.1% | 18.1% | 10.8% | 3.4% | 5.7% | 6.3% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 20,072 | 20,385 | 20,155 | 16,725 | 18,379 | 18,393 |
| Cash | 1,321 | 1,473 | 321 | 537 | 1,519 | 532 |
| Total debt | 6,665 | 6,248 | 6,246 | 5,954 | 7,273 | 6,526 |
| Total liabilities | 10,614 | 10,091 | 10,040 | 8,835 | 10,313 | 9,756 |
| 9,437 | 10,273 | 10,097 | 7,875 | 8,052 | 8,620 | |
| 98 | 98 | 92 | 88 | 84 | 84 | |
| 12.0% | 14.6% | 6.9% | 4.4% | 6.0% | 6.9% | |
| 16.5% | 23.1% | 12.7% | 5.3% | 9.3% | 10.2% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 2,135 | 3,110 | 1,956 | 1,328 | 1,586 | 1,641 | |
| 382 | 422 | 429 | 454 | 490 | 435 | |
| 1,754 | 2,688 | 1,527 | 874 | 1,096 | 1,206 | |
| Dividends paid | – | – | 195 | 254 | 243 | 241 |
| 100 | 1,669 | 1,100 | 1,000 | 250 | 450 | |
| 112 | 133 | 117 | 129 | 117 | 126 |
Valuation
- 34.5×
- 20.7×
- –
- 2.4×
- 2.2×
- 25.1×
- 18.0×
- 4.0%
- 2.9%
- 1.2%
Profitability
- 28.8%
- 10.9%
- 6.3%
- 14.7%
- 7.5%
- 7.1%
- 10.9%
- 4.9%
- 9.5%
- –
Growth
- −0.0%
- −8.0%
- +10.0%
- –
- −3.7%
Financial health
- 3.0×
- 0.83
- 37.9%
- 7.0×
- 1.73
- 1.54
- 0.74
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 42%of 952
Top 46%of 883
Bottom 38%of 576
Bottom 15%of 870
Top 28%of 985
What analysts expect
- Average price target
- $311.33
- Range
- $300.00 – $334.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 4.25 | 4.09 | +3.9% |
| Feb 17, 2026 | 4.07 | 3.95 | +3.0% |
| Oct 28, 2025 | 4.18 | 4.13 | +1.2% |
| Jul 24, 2025 | 4.35 | 4.17 | +4.3% |
| Apr 29, 2025 | 3.84 | 3.74 | +2.7% |
| Feb 6, 2025 | 3.45 | 3.39 | +1.8% |
| Oct 24, 2024 | 3.50 | 3.47 | +0.9% |
| Aug 1, 2024 | 3.94 | 3.78 | +4.2% |
1.2%of the share price, paid each year
On $1,000 invested$12a year at today's yield, before tax
–per share
Raised–not every year
Paid per share, each year
$1.86 in 2022 → $2.88 in 2025
How safe it looks
27.5% of its profit
Room to growStretchedMore than it earns: 20.0%
News
Stock Market Today: Dow, Nasdaq Rise After No Fed Rate Hike; Labcorp Blasts OffYahoo Finance · Oct 28, 2026Labcorp, Quest fall as CMS cuts 2027 rates for laboratory servicesSeeking Alpha · Sep 21, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
45No pass
Philip Fisher
30No pass
Peter Lynch
18No pass
Joel Greenblatt
11No pass
Charlie Munger
30No pass
Terry Smith
31No pass
Questions about Labcorp Holdings
Is Labcorp Holdings a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Labcorp Holdings AI analysis
What does Labcorp Holdings do?
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. It is in Medical - Diagnostics & Research, based in Burlington, NC, United States, with 71,000 employees.
Does Labcorp Holdings pay a dividend?
Yes. At today's price the dividend is 1.2% a year, about 27% of its yearly profit. In 2025 it paid out $241 million in dividends.
Is Labcorp Holdings stock halal?
Yes. Labcorp Holdings passes our halal screen: its business is permitted and its debt is 22% of its market value, under the 30% limit. How we check
How has Labcorp Holdings stock done over the past year?
Up 40.0% over the past twelve months, to $372.32. It traded between $250.39 and $372.32, close to its high.
Who are Labcorp Holdings's competitors?
The largest listed companies in the same industry are Illumina, Quest Diagnostics, Guardant Health and Exact Sciences. The peers table on this page compares their profit, growth and price with Labcorp Holdings's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.